Leadership

READDI team

READDI brings together the worlds brightest scientific, business and policy minds to meet the critical challenge of pandemic preparedness.

Angela Kashuba

Angela Kashuba

Interim CEO

Full Profile

Kelly Collins

Kelly Collins

Interim Chief Strategy and Development Officer

Full Profile

Nathaniel Moorman

Nathaniel Moorman

Co-founder and Interim Chief Scientific Officer

Full Profile

Ava Vargason

Ava Vargason

Scientific Program Manager

Full Profile

Mark Heise

Mark Heise

Co-founder and Scientific Adviser

Full Profile

Ralph S. Baric

Ralph S. Baric

Co-founder

Full Profile

Board of Directors

Richard Burr

Richard Burr

Principal Policy Advisor/Chair, Health Policy Strategic Consulting practice, DLA Piper
Former U.S. Senator, North Carolina

Full Profile

Laurent Fraisse

Laurent Fraisse

Research & Development Director, Drugs for Neglected Diseases Initiative

Full Profile

Lydia Ogden

Lydia Ogden

Global Public Health R&D Policy and External Engagement Leader, Johnson & Johnson

Full Profile

John Bamforth

John Bamforth

Executive Director, Eshelman Innovation, UNC-Chapel Hill

Full Profile

The purpose of READDI is to harness all the smart people toward the specific objective of making medicines to prevent the next pandemic.”